Robust designs in non-inferiority three arm clinical trials with presence of heteroscedasticity
نویسندگان
چکیده
In this paper, we describe an adjusted method to facilitate a non-inferiority trial by a three-arm robust design. Because local optimal designs derived in Hasler et al. [2007] require knowledge about the ratios of the population variances and are not necessarily robust with respect to possible misspecifications, a maximin approach is adopted. This method requires only the specification of an interval for the of variance ratios and yields robust and efficient designs. We demonstrate that a maximin optimal design only depends on the boundary points specified for the intervals of the variance ratios and receive numerical and analytical solutions. The derived designs are robust and very efficient for statistical analysis in non inferiority three arm trials.
منابع مشابه
Pivotal trials of orthopedic surgical devices in the United States: predominance of two-arm non-inferiority designs
BACKGROUND The United States Food and Drug Administration (FDA) reviews class III orthopedic devices submitted for premarket approval with pivotal clinical trials. The purpose of this study was to determine the types of orthopedic devices reviewed, the design of their pivotal clinical trials, and the subjective factors affecting the interpretation of clinical trial data. METHODS Meetings of t...
متن کاملTesting non-inferiority of a new treatment in three-arm clinical trials with binary endpoints
BACKGROUND A two-arm non-inferiority trial without a placebo is usually adopted to demonstrate that an experimental treatment is not worse than a reference treatment by a small pre-specified non-inferiority margin due to ethical concerns. Selection of the non-inferiority margin and establishment of assay sensitivity are two major issues in the design, analysis and interpretation for two-arm non...
متن کاملSome essential considerations in the design and conduct of non-inferiority trials.
BACKGROUND Suppose a standard therapy (Standard) has been established to provide a clinically important reduction in risk of irreversible morbidity or mortality. In that setting, the safety and efficacy of an experimental intervention likely would be assessed in a clinical trial providing a comparison with Standard rather than a placebo arm. Such a trial often is designed to assess whether the ...
متن کاملDesign and analysis of three-arm trials with negative binomially distributed endpoints.
A three-arm clinical trial design with an experimental treatment, an active control, and a placebo control, commonly referred to as the gold standard design, enables testing of non-inferiority or superiority of the experimental treatment compared with the active control. In this paper, we propose methods for designing and analyzing three-arm trials with negative binomially distributed endpoints...
متن کاملMeeting the demand for more sophisticated study designs. A proposal for a new type of clinical trial: the hybrid design
Background Treatment effect is traditionally assessed through either superiority or non-inferiority clinical trials. Investigators may find that because of safety concerns and/or wide variability across strata of the superiority margin of active controls over placebo, neither a superiority nor a non-inferiority trial design is ethical or practical in some disease populations. Prior knowledge ma...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2007